Results 231 to 240 of about 3,243,743 (388)

Efectos del ayuno intermitente sobre el rendimiento y la composición corporal de los deportistas. Revisión sistemática

, 2023
Virginia Tejada-Medina, Daniel Domínguez Ramírez, Ricardo Martín-Moya   +2 more
openalex   +2 more sources

Small and medium enterprise strategy: a review of literature Estrategia de pequeñas y medianas empresas: una revisión Estratégia de pequenas e médias empresas: uma revisão

REGE Revista de Gestão, 2010
A literature review highlights the evolution of studies about the strategy of small and medium enterprises (SME) and points out some research needs. Studies on the traditional perspective of the subject (which is prescriptive and based on design, formal planning and positioning) are included as well as contributions and limitations.
openaire   +1 more source

Insights Into the Antigenic Repertoire of Unclassified Synaptic Antibodies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We sought to characterize the sixth most common finding in our neuroimmunological laboratory practice (tissue assay‐observed unclassified neural antibodies [UNAs]), combining protein microarray and phage immunoprecipitation sequencing (PhIP‐Seq). Methods Patient specimens (258; 133 serums; 125 CSF) meeting UNA criteria were profiled;
Michael Gilligan, John R. Mills, Paulina Vargas, Naveen K. Paramasivan, Connie E. Lesnick, Eati Basal, Surendra Dasari, James P. Fryer, Shannon R. Hinson, Joseph Laporta, Amy Espinal, Dennis Fitzgerald, Carolina Garcia, Anna E. Morenkova, Paola Pergami, Anna Shah, Andrew Knight, Reghann LaFrance Corey, Vanda A. Lennon, Anastasia Zekeridou, Sean J. Pittock, Divyanshu Dubey, Andrew McKeon   +22 more
wiley   +1 more source

The risk of revision using tourniquet or not in primary total knee replacement: an observational study from the Swedish Knee Arthroplasty Register. [PDF]

Acta Orthop
W-Dahl A, Kärrholm J, Arani PI, Rolfson O.   +3 more
europepmc   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Enfermedad de Legg-Perthes-Calvé recurrente. Descripción de un caso y revisión de la literatura. [Recurrent Legg-Perthes-Calvé disease. A case report and literature review]

Revista de la Asociación Argentina de Ortopedia y Traumatología, 2015
Elena Martín Flores, Ángel Palazón Quevedo   +1 more
doaj   +1 more source

Dynamic Assessment as a Self-Regulation Strategy in the Acquisition of Textual Revision. [PDF]

Behav Sci (Basel)
Arias-Gundin O, Rodríguez C, Fidalgo R.
europepmc   +1 more source

Revisión sistemática sobre factores psicológicos y rendimiento académico en estudiantes universitarios durante la pandemia COVID-19

, 2023
Alexandra Valeria Villagómez Cabezas, Edison Fernando Bonifaz Aranda, Edison Paúl Barba Tamayo, Sintia Elizabeth Monge Patiño   +3 more
openalex   +2 more sources

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Outcomes following manufacturer-mismatched implants in primary and revision shoulder arthroplasty. [PDF]

Shoulder Elbow
Sogbein OA, Cox RM, Shen A, Lopez R, Fellheimer HS, Mowers C, Kurowicki J, Garrigues GE, Nicholson GP, Williams GR, Namdari S.   +10 more
europepmc   +1 more source